Additionally, factors such as oxidative stress, chronic inflammation, certain anti-diabetic medications, erythropoietin hypo-responsiveness, diabetic neuropathy, elevated levels of advanced glycation end products, and impaired erythropoietin response could contribute to anemia in individuals with T2DM [29, 30]. This evidence concerns the gene EPO and diabetic neuropathy.